Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome-Reference-Cited by-同舟云学术

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

Published:2019-07-03 Issue:10 Volume:8 Page:e1629780
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Noblejas-López María del Mar¹,Nieto-Jiménez Cristina¹,Morcillo García Sara¹,Pérez-Peña Javier¹,Nuncia-Cantarero Miriam¹,Andrés-Pretel Fernando¹,Galán-Moya Eva M.¹,Amir Eitan²,Pandiella Atanasio³⁴,Győrffy Balázs⁵^ORCID,Ocana Alberto¹³⁶

Affiliation:

1. Translational Oncology Laboratory, Centro Regional de Investigaciones Biomedicas, Castilla‐La Mancha University (CRIB‐UCLM), Albacete, Spain

2. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada

3. Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain

4. CIC-Universidad de Salamanca, Salamanca, Spain

5. Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary and MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary

6. Experimental Therapeutics Unit, Medical Oncology Department, Hospital Clínico Universitario San Carlos, IDISSC and CIBERONC, Madrid, Spain

Funder

Fundación Científica Asociación Española Contra el Cáncer

Instituto de Salud Carlos III

CRIS Cancer Foundation

Secretaría de Estado de Investigación, Desarrollo e Innovación

Universidad de Castilla-La Mancha

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link